查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1879261

藥物依從性市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、藥物、地區和競爭格局分類，2020-2030年預測

Medication Adherence Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Medication, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球藥物依從性市場規模為26.6億美元，預計2030年將以5.30%的複合年成長率成長至36.3億美元。藥物依從性解決方案涵蓋旨在確保患者持續遵循處方藥物方案（包括劑量、用藥時間和頻率）的技術和服務。此市場成長的主要促進因素包括：慢性疾病（如糖尿病和心血管疾病）在全球範圍內的日益流行；需要長期治療的老年人口不斷成長；以及醫療保健技術的不斷進步，包括智慧型手機在健康管理領域的廣泛應用。此外，以患者為中心的護理模式的日益普及以及醫療保健生態系統內合作的不斷加強也進一步推動了該市場的發展。

市場概覽
預測期 2026-2030
2024年市場規模 26.6億美元
2030年市場規模 36.3億美元
2025-2030年複合年成長率 5.3%
成長最快的細分市場 腫瘤學
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球藥物依從性市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（硬體中心型、軟體中心型）
    • 依藥物分類（心血管、中樞神經、糖尿病、腫瘤、胃腸道、肌肉骨骼、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美藥物依從性市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲藥物依從性市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區藥物依從性市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲藥物依從性市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲藥物依從性市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球藥物依從性市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • AdhereTech Inc.
  • Cardinal Health Inc.
  • Everwell Technology Ltd
  • InhandPlus Inc.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • McKesson Corporation
  • MedAdvisor International Pty Ltd
  • Medminder Systems, Inc.
  • Omnicell, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 19888

The Global Medication Adherence Market, valued at USD 2.66 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 3.63 Billion by 2030. Medication adherence solutions encompass technologies and services designed to ensure patients consistently follow prescribed medication regimens concerning dosage, timing, and frequency. This market's growth is primarily driven by the escalating global prevalence of chronic diseases, such as diabetes and cardiovascular conditions, the expanding geriatric population requiring long-term treatment, and continuous advancements in healthcare technology, including widespread smartphone adoption for health management. Further impetus comes from a growing emphasis on patient-centric care models and increasing collaborations across the healthcare ecosystem.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.66 Billion
Market Size 2030USD 3.63 Billion
CAGR 2025-20305.3%
Fastest Growing SegmentOncology
Largest MarketNorth America

Key Market Drivers

The escalating prevalence of chronic diseases represents a primary driver for the global medication adherence market. Conditions such as diabetes, cardiovascular disease, and respiratory ailments necessitate long-term medication regimens, often complex, for effective management and prevention of severe complications. The sheer scale of this challenge underscores the critical need for solutions that support consistent patient adherence. According to the International Diabetes Federation, in 2024, 589 million adults aged 20 to 79 years are living with diabetes, a condition demanding rigorous medication adherence to mitigate serious health consequences and healthcare burdens.

Key Market Challenges

The high cost of pharmaceuticals and patient cost-sharing presents a significant challenge to the growth of the Global Medication Adherence Market. When medication expenses become prohibitive, patients frequently resort to strategies such as reducing prescribed dosages, delaying refills, or entirely discontinuing essential treatments. This financial impediment directly undermines the utility and adoption of medication adherence solutions, as patients prioritize immediate cost reduction over long-term health management facilitated by adherence technologies.

Key Market Trends

The integration of Artificial Intelligence in adherence monitoring is fundamentally transforming how patients engage with their prescribed treatments. AI-powered platforms leverage advanced algorithms to analyze patient behavior, identify non-adherence patterns, and deliver highly personalized interventions, moving beyond generic reminders. These intelligent systems facilitate predictive analytics to pinpoint individuals at high risk of non-adherence, enabling proactive support. According to American Medical Association survey data, 66% of physicians reported using AI in their practices in 2024, a significant increase from 38% in 2023, demonstrating growing adoption of AI in clinical settings. This technological shift enhances the effectiveness of medication management by tailoring support to individual patient needs.

Key Market Players

  • AdhereTech Inc.
  • Cardinal Health Inc.
  • Everwell Technology Ltd
  • InhandPlus Inc.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • MedAdvisor International Pty Ltd
  • Medminder Systems, Inc.
  • Omnicell, Inc.

Report Scope:

In this report, the Global Medication Adherence Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medication Adherence Market, By Type:

  • Hardware Centric
  • Software Centric

Medication Adherence Market, By Medication:

  • Cardiovascular
  • Central Nervous System
  • Diabetes
  • Oncology
  • Gastrointestinal
  • Musculoskeletal
  • Others

Medication Adherence Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Medication Adherence Market.

Available Customizations:

Global Medication Adherence Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medication Adherence Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Hardware Centric, Software Centric)
    • 5.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Medication Adherence Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Medication
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Medication Adherence Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Medication
    • 6.3.2. Canada Medication Adherence Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Medication
    • 6.3.3. Mexico Medication Adherence Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Medication

7. Europe Medication Adherence Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Medication
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Medication Adherence Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Medication
    • 7.3.2. France Medication Adherence Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Medication
    • 7.3.3. United Kingdom Medication Adherence Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Medication
    • 7.3.4. Italy Medication Adherence Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Medication
    • 7.3.5. Spain Medication Adherence Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Medication

8. Asia Pacific Medication Adherence Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Medication
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Medication Adherence Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Medication
    • 8.3.2. India Medication Adherence Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Medication
    • 8.3.3. Japan Medication Adherence Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Medication
    • 8.3.4. South Korea Medication Adherence Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Medication
    • 8.3.5. Australia Medication Adherence Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Medication

9. Middle East & Africa Medication Adherence Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Medication
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Medication Adherence Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Medication
    • 9.3.2. UAE Medication Adherence Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Medication
    • 9.3.3. South Africa Medication Adherence Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Medication

10. South America Medication Adherence Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Medication
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Medication Adherence Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Medication
    • 10.3.2. Colombia Medication Adherence Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Medication
    • 10.3.3. Argentina Medication Adherence Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Medication

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Medication Adherence Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. AdhereTech Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cardinal Health Inc.
  • 15.3. Everwell Technology Ltd
  • 15.4. InhandPlus Inc.
  • 15.5. Johnson & Johnson
  • 15.6. Koninklijke Philips N.V.
  • 15.7. McKesson Corporation
  • 15.8. MedAdvisor International Pty Ltd
  • 15.9. Medminder Systems, Inc.
  • 15.10. Omnicell, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer